期刊文献+

儿童慢性肝炎抗病毒治疗药物的不良反应及处理 被引量:7

The side effect of antiviral therapy for chronic hepatitis B in children
原文传递
导出
摘要 以干扰素为基础的抗病毒治疗儿童慢性乙型及丙型肝炎已是共识,且取得了较好的疗效。但干扰素、病毒唑治疗中可引起不同程度不良反应,一些不良反应会影响儿童用药的依从性及疗程的完成,从而影响抗病毒疗效[1-3]。因此,充分了解抗病毒治疗药物的不良反应、密切观察及早发现不良反应并采取恰当的处理措施是提高抗病毒疗效的关键之一。
作者 朱世殊
机构地区 北京解放军
出处 《中国实用儿科杂志》 CSCD 北大核心 2010年第12期909-912,共4页 Chinese Journal of Practical Pediatrics
关键词 儿童 慢性病毒性肝炎 抗病毒治疗 children chronic viral hepatitis antiviral therapy
  • 相关文献

参考文献19

  • 1Al-Mahtab M, Rahman S, Akbar SM, et al. Combination therapy of lamivudine and interferon-alpha in pediatric patients with chronic hepatitis B in Bangladesh: a safe and effective therapeutic approach for pediatric CHB patients in developing countries [J]. Int J Immunopathol Pharmacol, 2010, 23 (2) : 659-664.
  • 2Wirth S, Ribes-Koninckx C, Calzado MA, et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin [J]. J Hepatol, 2010,52(4) :501-507.
  • 3张鸿飞.儿童慢性乙型肝炎的抗病毒治疗[J].中华肝脏病杂志,2010,18(7):495-497. 被引量:22
  • 4张鸿飞,杨晓晋,朱世殊,鲍鹤玫,王陆军,徐志强,陈大为.α干扰素治疗小儿慢性肝炎副作用的长期观察[J].中华实验和临床病毒学杂志,2000,14(4):376-378. 被引量:21
  • 5Zhu SS, Zhang HF, Dong Yi, et al. Evaluation of the effect of extended peginterferon- α-2a therapy on physical and psychologyical development in children with HBeAg positive chronic hepatitis B[C]. APASL,2010:252.
  • 6JessnerW, Kinaeiyan T, Formann E, et al. Severe skin reactions during therapy for ehronie hepatitis C associated with delayed hypersensitivity to pegylated interferon[J]. Hepatology, 2002,36 (4).-361.
  • 7Rodrigue JR, Balistreri W, Haher B, et al. Impact of hepatitis C virus infection on children and their caregivers : quality of life, cognitive, and emotional outcomes [J].J Pediatr Gastroenterol, 2009,48(3 ) : 341-347.
  • 8Zdilar D, Franco-broneon K, Buchler N, et al. Hepatitis C, interferon alfa, and depression [J]. Hepatology, 2000, 31: 1207-1211.
  • 9张鸿飞 朱世殊 董漪 等.干扰素治疗致血液学不良反应与骨髓象关系的初步研究.中华传染病杂志,2008,12:18-22.
  • 10张鸿飞,杨晓晋,朱世殊,董漪,陈大为,贾文峥,徐志强,毛远丽,唐红梅.聚乙二醇α干扰素治疗54例小儿慢性丙型肝炎报道[J].中华实验和临床病毒学杂志,2005,19(2):185-187. 被引量:16

二级参考文献42

  • 1徐道振,谢尧,陆志檬,骆抗先,贾继东,王宇明,赵桂珍,张树林,张大志.聚乙二醇干扰素α-2a与干扰素α-2a治疗慢性丙型肝炎疗效、安全性的评估[J].中华传染病杂志,2004,22(4):221-224. 被引量:37
  • 2张鸿飞,杨晓晋,朱世殊,董漪,陈大为,贾文峥,徐志强,毛远丽,唐红梅.聚乙二醇α干扰素治疗54例小儿慢性丙型肝炎报道[J].中华实验和临床病毒学杂志,2005,19(2):185-187. 被引量:16
  • 3张鸿飞,朱世殊,杨晓晋,徐志强,董漪,陈大为,赵景民,陈菊梅,张太和.小儿乙、丙型肝炎临床与病理研究[J].传染病信息,2006,19(3):130-131. 被引量:25
  • 4张鸿飞,杨晓晋,李捍卫,陈菊梅,朱世殊,王陆军,兰红,徐志强,钟小敏.重组干扰素α-2b治疗小儿慢性丙型肝炎及相关因素的前瞻性研究[J].中华实验和临床病毒学杂志,1996,10(4):378-380. 被引量:5
  • 5Broderick A,Jonas MM.Management of hepatitis B in children.Clin Liver Dis,2004,8:387-401.
  • 6骆抗先.乙型肝炎基础和临床.3版.北京:人民卫生出版社,2001:224-226.
  • 7Sokal EM,Conjeevaram HS,Roberts EA,et al.Interferon alfa therapy for chronic hepatitis B in children:a multinational randomized controlled trial.Gsatroentcrology,1998,114:988-995.
  • 8Torte D,Tambini R.Interferon-alhpa therapy for chronic hepatitis B in children:a meta-analysis.Clin Infect Dis,1996,23:131-137.
  • 9Vajro P,Tedesco M,Fontanella A,et al.Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.Pediatr Infect Dis J,1996,15:223-231.
  • 10Zhu SS,Zhang HF,Dong Y,et al.Evaluation of safety and efficacy of extended pegainterferon-α-2a therapy in children with HBeAgpositive chronic hepatitis B.The 20th Conference of the Asion Pacific Association for the Study of Liver,Beijing 2010:161.

共引文献62

同被引文献119

  • 1陈大为,张鸿飞,董漪,钟彦伟,徐志强,甘雨,贾文铮,王福川,王丽旻,朱世殊.慢性乙型肝炎儿童中的自身抗体检测分析及临床意义初探[J].中华临床医师杂志(电子版),2011,5(15):4336-4339. 被引量:8
  • 2张鸿飞,杨晓晋,朱世殊,董漪,陈大为,贾文峥,徐志强,毛远丽,唐红梅.聚乙二醇α干扰素治疗54例小儿慢性丙型肝炎报道[J].中华实验和临床病毒学杂志,2005,19(2):185-187. 被引量:16
  • 3郑修文,钱文,高瑞银,杭太俊,张正行.HPLC测定利可君原料药中主药含量和有关物质[J].中国药学杂志,2006,41(14):1105-1108. 被引量:13
  • 4张鸿飞,朱世殊,杨晓晋,徐志强,董漪,陈大为,赵景民,陈菊梅,张太和.小儿乙、丙型肝炎临床与病理研究[J].传染病信息,2006,19(3):130-131. 被引量:25
  • 5张鸿飞 朱世殊 董漪 等.干扰素治疗致血液学不良反应与骨髓象关系的初步研究.中华传染病杂志,2008,12:18-22.
  • 6Al-Mahtab M, Rahman S, Akbar SM, et al. Combination therapy of lamivudine and interferon-alpha in pediatric patients with chronic hepatitis B in Bangladesh:a safe and effective therapeutic approach for pediatric CHB patients in developing countries. Int J Immunopathol Pharmacol,2010 ,23 :659-664.
  • 7Wirth S,Ribes-Koninckx C, Calzado MA, et al. High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfao2b plus ribavirin. Hepatol. 2010,52: 501-507.
  • 8Fried MW. Side effects of therapy for hepatitis C and their management. Hepatology. 2002,36 : S237-S244.
  • 9中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010版)[J].临床肝胆病杂志,2011,27(1):1-16.
  • 10Jonas MM, Block JM, Haber BA, et al. Treatment of chil- dren with chronic hepatitis B virus infection in the United states, patient selection and therapeutic options[ J ]. Hepa- tology, 2010, 52(6):2192 -2205.

引证文献7

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部